Why the length of recurrence-free survival or ‘lead-times’ can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis

• Steven Sorscher

Affiliations

Steven Sorscher